Professor Gavin Halbert

Strathclyde Institute of Pharmacy and Biomedical Sciences

Personal statement

I obtained a pharmacy degree from the University of Strathclyde in 1979 followed by a PhD in Physiochemical Aspects of Anti-Cancer Drug Targeting Systems in 1984. I worked during pre-registration in industrial and hospital pharmacy settings, joined SIPBS as a lecturer in 1984 and was appointed Director of the Formulation Unit in 1992. The Unit's role is to characterise, analyse, formulate and manufacture putative anti-cancer drugs accepted by CRUK's New Agents Committee for use in human clinical trials, where I have now been pharmaceutically responsible for over 20 novel NCE's. Arising from this are research interests, which include medicinal and analytical chemistry, drug physiochemistry, formulation for both small volume and parenteral and oral products and the GMP production of specialist pharmaceutical products for phase l clinical trials. The latter incorporates research areas such as microbiology and lyophilisation. In addition related research is conducted in drug targeting and delivery systems for cancer chemotherapy for example the utilisation of synthetic Low Density Lipoprotein systems. I have over £10 million in personal career grant income and over 150 published papers, conference abstracts and presentations.

Undergraduate teaching is limited due to the nature of the Formulation Unit's activities to introductory and specialist courses associated with the areas above applicable to undergraduate pharmacists. Since 1987 I have been involved in post qualification education teaching for the pharmaceutical industry and initiated and teach on the joint SIPBS-David Begg Associates Qualified Persons training course which has been running since 1991.


Solid dispersions : improving drug performance through tablet micro-structure design
Prasad Elke, Robertson John, Halbert Gavin W
American Association of Pharmaceutical Scientists (AAPS) 2021 PharmSci 360 (2021)
Quality control test for pharmaceutical feedstock material for FDM 3D printers
Prasad Elke, Robertson John, Halbert Gavin W
Virtual PharmSci (2021)
Mechanical characterisation of an FDM 3D printing process
Prasad Elke, Robertson John, Halbert Gavin W
Virtual PharmSci (2021)
Printability of pharmaceutical polymers in FDM 3D printers
Prasad Elke, Robertson John, Halbert Gavin W
Virtual PharmSci (2021)
Small scale in vitro method to determine a bioequivalent equilibrium solubility range for fasted human intestinal fluid
Abuhassan Qamar, Khadra Ibrahim, Pyper Kate, Halbert Gavin W
European Journal of Pharmaceutics and Biopharmaceutics Vol 168, pp. 90-96 (2021)
Manufacturing considerations for the development of lipid nanoparticles using microfluidics
Roces Carla B, Lou Gustavo, Jain Nikita, Abraham Suraj, Thomas Anitha, Halbert Gavin W, Perrie Yvonne
Pharmaceutics Vol 12 (2020)

More publications

Professional activities

ToF-SIMS imaging of amorphous solid dispersions: a stability study
3D imaging of controlled-release electrospun material
ToF-SIMS imaging of pharmaceutical samples: case-studies
Cencer Research UK (External organisation)
Invited talk at BPC September 2009
Invited speaker
Controlled Release Society , USA
Keynote/plenary speaker

More professional activities


Doctoral Training Partnership 2020-2021 University of Strathclyde | Ugorenko, Agata
Perrie, Yvonne (Principal Investigator) Halbert, Gavin (Co-investigator) Ugorenko, Agata (Research Co-investigator)
01-Jan-2021 - 01-Jan-2024
Multiscale Metrology Suite for Next-generation Healthcare Technologies (EPSRC Strategic Equipment)
Rattray, Zahra (Principal Investigator) Bruns, Nico (Co-investigator) Faulds, Karen (Co-investigator) Graham, Duncan (Co-investigator) Halbert, Gavin (Co-investigator) Hoskins, Clare (Co-investigator) McArthur, Stephen (Co-investigator) Perrie, Yvonne (Co-investigator) Reid, Stuart (Co-investigator) Seib, Philipp (Co-investigator)
01-Jan-2021 - 31-Jan-2024
Cancer Research UK Formulation Unit for the pharmaceutical and bio-pharmaceutical evaluation of new anti-cancer drugs C149/A28424
Halbert, Gavin (Principal Investigator) Cygan Barlow, Paulina (Co-investigator) Dick, Lindsay (Co-investigator) Elliott, Moira (Co-investigator)
Cancer Research UK Formulation Unit Quinquennial Proposal year 1
01-Jan-2020 - 30-Jan-2021
Development of a first-in-class IKKalpha inhibitor for the treatment of castrate resistant p
MacKay, Simon (Principal Investigator) Halbert, Gavin (Co-investigator) Paul, Andrew (Co-investigator) Suckling, Colin (Co-investigator) Watson, David (Co-investigator)
01-Jan-2020 - 30-Jan-2022
CONTIMED High Growth Spinout Program
Florence, Alastair (Principal Investigator) Halbert, Gavin (Co-investigator) Robertson, John (Co-investigator)
22-Jan-2020 - 22-Jan-2021
Pressure-dependent In-Situ Monitoring of Granular Materials
Florence, Alastair (Principal Investigator) Halbert, Gavin (Co-investigator) Markl, Daniel (Co-investigator) McArthur, Stephen (Co-investigator) Nordon, Alison (Co-investigator) Oswald, Iain (Co-investigator)
01-Jan-2019 - 31-Jan-2022

More projects


Strathclyde Institute of Pharmacy and Biomedical Sciences
Robertson Wing

Location Map

View University of Strathclyde in a larger map